Newsroom

Sorted by: Latest
-

Cotchett, Pitre & McCarthy Announces Opening of $250 Million Apple AI False Advertising Settlement Claims Period

SAN JOSE, Calif.--(BUSINESS WIRE)--Cotchett, Pitre & McCarthy announced today the beginning of the 90-day Notice Period during which Class Members can submit their claims in this landmark settlement. On July 17, 2026, Judge Noël Wise of the U.S. District Court for the Northern District of California granted preliminary approval of this $250,000,000 Settlement with Apple in this nationwide false advertising class action concerning “Apple Intelligence” on iPhones. Plaintiffs allege that Apple...
-

BellRing Brands Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of BellRing Brands, Inc. - BRBR

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into BellRing Brands, Inc. (NYSE: BRBR) (“BellRing” or the “Company”). On August 4, 2025, the Company reported its fiscal 3Q 2025 financial results, disclosing a disappointing new 2025 sales outlook, stating “BellRing management has narrowed its fiscal year 2025 outlook f...
-

MISTRAS Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of MISTRAS Group, Inc. - MG

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of MISTRAS Group, Inc. (NYSE: MG) to affiliates of H.I.G. Capital. Under the terms of the proposed transaction, shareholders of MISTRAS will receive $20.35 in cash for each share of MISTRAS that they own. KSF is seeking to determine whether this consideration and the process that led to it are ade...
-

PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). PROCEPT is a medical technology company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegat...
-

K-Era Fest Brings the Korean Wave to the Pacific Northwest October 24-25

SEATTLE--(BUSINESS WIRE)--The Pacific Northwest's first, large-scale Korean Wave festival arrives Oct 24-25 featuring global talent, cultural leaders and industry icons....
-

MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors

LYON, France--(BUSINESS WIRE)--MaaT Pharma Announces Upcoming Pre-IND Meeting with the FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors...
-

MaaT Pharma annonce la tenue prochaine d’une réunion pré-IND avec la FDA et poursuit l’avancement de MaaT034 vers son développement clinique dans les tumeurs solides

LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET) visant à améliorer la survie des patients atteints de cancer grâce à la modulation du système immunitaire, annonce aujourd’hui les prochaines étapes du développement clinique de MaaT034, premier écosystème microbien co-cultivé et sélectionné sur la base de ses fonctions, issu de...
-

ABL Texcell Diagnostics Reaches a New Strategic Milestone With a Proposed Acquisition of Vela Diagnostics' Activities in Singapore and the United States

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the "Company"), a company specializing in molecular diagnostic solutions, healthcare software and clinical research services, announces that it has signed, alongside Advanced Biological Laboratories S.A. (ABL), its parent company, a non-binding letter of intent for a proposed acquisition of 100% of the share capital of Vela Operations Singapore Pte. Ltd. and Vela Diagnostics USA Inc. T...
-

ABL Texcell Diagnostics franchit une nouvelle étape stratégique avec un projet d’acquisition des activités de Vela Diagnostics à Singapour et aux États-Unis

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris : ABLD – ISIN : FR001400AHX6) (la « Société »), société spécialisée dans les solutions de diagnostic moléculaire, les logiciels de santé et les services associés à la recherche clinique, annonce avoir signé, aux côtés d’Advanced Biological Laboratories S.A. (ABL), sa société-mère, une lettre d’intention non contraignante portant sur un projet d’acquisition de 100 % du capital de Vela Operations Singapore Pte. Ltd....
-

RXT Deadline: Rosen Law Firm Urges Rackspace Technology, Inc. (NASDAQ: RXT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Rackspace Technology, Inc. (NASDAQ: RXT) between May 6, 2026 and July 8, 2026, inclusive (the “Class Period”). Rackspace is a hybrid cloud and AI solutions company.For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.The Allegations: Rosen Law Firm is Investigating the Allegations t...